# Study of the Impact of VEGF Polymorphism on the Development of Renal Carcinoma in Renal Transplant Patients

> **NCT03114826** · — · UNKNOWN · sponsor: **Centre Hospitalier Universitaire, Amiens** · enrollment: 272 (estimated)

## Conditions studied

- Polymorphism
- VEGF
- Renal Carcinoma
- Renal Transplantation

## Interventions

- **GENETIC:** To study the polymorphism of the gene encoding VEGF (rs699947) as a predictive marker

## Key facts

- **NCT ID:** NCT03114826
- **Lead sponsor:** Centre Hospitalier Universitaire, Amiens
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-10-06
- **Primary completion:** 2019-10-05
- **Final completion:** 2019-10-05
- **Target enrollment:** 272 (ESTIMATED)
- **Last updated:** 2017-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03114826

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03114826, "Study of the Impact of VEGF Polymorphism on the Development of Renal Carcinoma in Renal Transplant Patients". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03114826. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*